Cancer Letters
Volume 241, Issue 1 , Pages 110-117 , 8 September 2006

Analysis of gene expression induced by microtubule-disrupting agents in HeLa cells using microarray

  • Sung Gook Cho

      Affiliations

    • Department of Biology, Kyung Hee University, 130-701 Seoul, Republic of South Korea
    • ,
  • Choong-Ryoul Sihn

      Affiliations

    • Department of Biology, Kyung Hee University, 130-701 Seoul, Republic of South Korea
    • ,
  • Soon Ji Yoo

      Affiliations

    • Department of Biology, Kyung Hee University, 130-701 Seoul, Republic of South Korea
    • ,
  • Kwang Keun Cho

      Affiliations

    • Department of Animal Resource Technology, Chinju National University, Chinju, Kyongnam 660-758, Republic of South Korea
    • ,
  • Hong-gu Lee

      Affiliations

    • School of Agricultural Biotechnology, Seoul National University, Seoul 151-742, Republic of South Korea
    • ,
  • Yun-Jaie Choi

      Affiliations

    • School of Agricultural Biotechnology, Seoul National University, Seoul 151-742, Republic of South Korea
    • ,
  • Sang Hoon Kim

      Affiliations

    • Department of Biology, Kyung Hee University, 130-701 Seoul, Republic of South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 961 9208; fax: +82 2 964 1079.

Received 29 May 2005 ,Revised 1 October 2005 ,Accepted 10 October 2005.

References 

  1. Sawin KK. Microtubule dynamincs: faint speckle, hidden dragon. Curr. Biol. 2004;14:702–704
  2. Welte MA. Bidirectional transport along microtubules. Curr. Biol. 2004;14:525–537
  3. Chen JG, Horwitz SB. Differential mitotic response to microtubule-stabilizing and -destabilizing drugs. Cancer Res. 2002;62:1935–1938
  4. Jordan MA, Thrower D, Wilson L. Effects of vinblastine, podophyllotoxin, and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J. Cell Sci. 1992;102:401–406
  5. Yvon AM, Wadsworth P, Jordan MA. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell. 1999;10:947–959
  6. Wilson L, Panda D, Jordan MA. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators. Cell Struct. Funct. 1999;24:329–335
  7. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer. 2004;4:253–265
  8. Hong FD, Chen J, Donovan S, Schneider N, Nisen PD. Taxole, vincristine or nocodazole induces lethality in G1-checkpoint-defective human astrocytoma U373MG cells by triggering hyperploid preogression. Carcinogenesis. 1999;20:1161–1168
  9. Yeung TK, Germond C, Chen X, Wang Z. The mode of action of Taxol: apoptosis at low concentration and necrosis at high concentration. Biochem. Biophys. Res. Commun. 1999;263:398–404
  10. Hoyt MA, Totis L, Roberts BT. S.cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell. 1991;66:507–517
  11. Rudner AD, Murray AW. The spindle assembly checkpoint. Curr. Opin. Cell Biol. 1996;8:773–780
  12. Khan SH, Wahl GM. p53 and pRb prevent re-replication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res. 1998;58:396–401
  13. Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell Biol. 1998;18:1055–1064
  14. Giannakakou P, Robey R, Fojo T, Blagosklonny MV. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene. 2001;20:3806–3813
  15. Hoffman B, Liebermann DA. The proto-oncogene c-myc and apoptosis. Oncogene. 1998;17:3351–3357
  16. Ivanova TV, Ivanov VN, Nadezhdina ES. Transcription factors NF-kappaB and AP-1/c-fos in cell response to nocodazole. Membr. Cell Biol. 2001;14:727–741
  17. Livak KJ, Schmittgen D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408
  18. Rieder CL, Maiato H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell. 2004;7:637–651
  19. Moinova HR, Chen W-D, Shen L, Markowitz SD. HLTF gene silencing in human colon cancer. Proc. Natl Acad. Sci. USA. 2002;99:4562–4567
  20. Sif S, Stukenberg PT, Kirschner MW, Kingston RE. Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. Genes Dev. 1998;12:2842–2851
  21. Xue Y, Canman JC, Lee CS, Nie Z, Yang D, Moreno GT, et al. The human SWI/SNF-B chromatin-remodeling complex is related to yeast Rsc and localizes at kinetochores of mitotic chromosomes. Proc. Natl Acad. Sci. USA. 2000;97:13015–13020
  22. Ainsztein AM, Kandels-Lewis SE, Mackary AM, Earnshaw WC. INCENP centromere and spindle targeting: Identification of essential conserved motifs and involvement of heterochromatin protein HP1. J. Cell Biol. 1998;143:1763–1774
  23. Wheatley SP, Carvalho A, Vagnarelli P, Earnshaw WC. INCENP is required for proper targeting of surviving to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 2001;11:886–890
  24. Bolton MA, Lan W, Powers SE, McCleland ML, Kuang J, Stukenberg PT. Aurora B kinase exists in a complex with surviving and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation. Mol. Biol. Cell. 2002;13:3064–3077
  25. Vigneron S, Prieto S, Bernis C, Labbe J-C, Castro A, Lorca T. Kinetochore localization of spindle checkpoint proteins: who controls whom?. Mol. Biol. Cell. 2004;15:4584–4596
  26. Canman JC, Sharma N, Straight A, Shannon KB, Fang G, Salmon ED. Anaphase onset does not require the microtubule-dependent depletion of kinetochore and centromere-binding proteins. J. Cell Sci. 2002;115:3787–3795
  27. Carvalho A, Carmena M, Sambade C, Earnshaw WC, Wheatley SP. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell Sci. 2003;116:2987–2998
  28. Lens SM, Wolthuis RM, Klompmaker R, Kauw J, Agami R, Kops G, et al. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. Eur. Mol. Biol. Org. J. 2003;22:2934–2947
  29. Chaturvedi P, Eng WK, Zhu Y, Mattern MR, Mishra R, Hurle MR, et al. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene. 1999;18:4047–4054
  30. Melo J, Toczyski D. A unified view of the DNA-damage checkpoint. Curr. Opin. Cell Biol. 2002;14:237–245
  31. Chehab NH, Malikzay A, Appel M, Halazonetis TD. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 2000;14:278–288
  32. Takai H, Naka K, Okada Y, Motoyama N. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. Eur. Mol. Biol. Org. J. 2002;21:5195–5205
  33. Wei JH, Chou YF, Ou YH, Yeh YH, Tyan SW, Sun TP, et al. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68. J. Biol. Chem. 2005;280:7748–7757
  34. Tsvetkov LM, Xu X, Li J, Stern DF. Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J. Biol. Chem. 2003;278:8468–8475

PII: S0304-3835(05)00935-3

doi: 10.1016/j.canlet.2005.10.015

Cancer Letters
Volume 241, Issue 1 , Pages 110-117 , 8 September 2006

Article Tools

* Image Usage & Resolution